Eikon Therapeutics has raised $381 million from its IPO, at the top end of its expectations, in another sign of a pickup in appetite for new biotech listings on the Nasdaq. The South San Francisco ...

Former MSD head of R&D Roger Perlmutter has continued the swift development track for cancer start-up Eikon Therapeutics, filing an IPO to build its already healthy cash position further. Eikon has ...

Investing.com - JPMorgan initiated coverage on Eikon Therapeutics Inc. (NASDAQ:EIKN) with an Overweight rating and set a price target of $29.00, analyst Brian Cheng said Monday. The target represents ...

Investing.com - BofA Securities initiated coverage on Eikon Therapeutics Inc. (NASDAQ:EIKN) with a Buy rating and a price target of $34.00. The stock currently trades at $13.78, near its 52-week low ...

Investing.com - Mizuho initiated coverage on Eikon Therapeutics Inc. (NASDAQ:EIKN) with an outperform rating and set a price target of $26.00. The target represents nearly 90% upside from the current ...

Somer G. Anderson is CPA, doctor of accounting, and an accounting and finance professor who has been working in the accounting and finance industries for more than 20 years. Her expertise covers a ...

All the Latest Game Footage and Images from Farewell, Eikon Sleeping on the job, running out of ice cream, and being locked out of his hometown due to a storm. Things just can’t seem to go right for ...

We may earn commission from links on this page, but we only recommend products we love. Promise. Listen, I’ll be the first person to tell you that homemade face masks can be a little questionable.

Eikon Therapeutics is a biopharmaceutical company. It engages in the development of medicines for unmet medical needs. The company was founded in 2019 and is headquartered in Millbrae, CA.

I Feel Love’s innovative electronic rhythm section set the stage for pretty much everything that followed, and here’s how you can recreate its bewitching energy in your DAW ...